According to crypto analyst Cas Abbé, Dogecoin’s current movement suggests it is stepping into a new expansion phase after an extended period of accumulation. This development comes after months of relatively muted sentiment with strong price support, which now appears to be forming the groundwork for another strong breakout. Notably, technical analysis of various charts tracking Dogecoin’s hash rate, CVDD levels, alpha pricing, and network stress index provides context to this technical outlook, which might see Dogecoin surge to new price highs.

Signs Of An Expansion Phase In Dogecoin

Taking to the social media platform X, crypto analyst Cas Abbé explained a few reasons as to why the Dogecoin price is about to enter into an expansion phase. The first being that Dogecoin has been trading inside a wide accumulation range in the past few months. This base has been at the $0.20 price level since the beginning of August.

This type of prolonged base-building is mostly always known to precede sharp upward moves, as it reflects the gradual buildup of strong demand. Furthermore, the analyst noted that the current breakout attempts are backed by rising trading volume, which he interpreted as institutional accumulation. This is unlike past Dogecoin bull cycles, which were mostly based on retail hype.

Technical momentum indicators such as the Relative Strength Index (RSI) are currently in a mid-range position, and this means that Dogecoin still has significant room to climb before hitting overbought conditions.

Another factor is the Dogecoin mining hash rate chart. As shown in the image below, the hash rate has been rising massively since the beginning of 2025, showing that network strength has been steadily climbing even during price consolidations and declines.

Historical Patterns Back Expansion Outlook

One of Abbé’s key points is that Dogecoin’s price cycles have consistently followed a similar pattern of long sideways stretches followed by sudden vertical expansions. This cycle structure can be seen in the cumulative value days destroyed (CVDD) chart. As shown in the chart below, Dogecoin’s price action stayed well within its accumulation zones before breaking higher in 2018 and then in 2021.

However, unlike the peaks in 2018 and 2021 where on-chain metrics were overheated, current conditions are calm, which shows more of genuine accumulation rather than profit-taking and distribution.

The expansion phase is not about short-lived spikes but rather the start of a new directional trend that could redefine Dogecoin’s price structure. Although the analyst did not define a price target, technical analyses from other analysts point to price predictions that will take the Dogecoin price well above its 2021 peak of $0.7316 into the $1 threshold and beyond. A similar analysis by crypto analyst Javon Marks points to a Dogecoin price target of $1.25.

At the time of writing, Dogecoin is trading at $0.237, up by 9.5% in the past 24 hours.

Featured image from Unsplash, chart from TradingView

Billionaire Jeffrey Gundlach is warning that the US dollar is very close to triggering a collapse amid its sustained weakness this year.

In a new video update, the DoubleLine Capital CEO says he’s keeping a close watch on the US dollar index (DXY), which tracks the performance of the USD against a basket of foreign currencies.

Gundlach points out that the DXY has been in a macro downtrend, and he expects the US dollar index to melt down if it loses a diagonal trendline that has held as support since 2011.

“The dollar has been in a pattern of lower highs going back to 1985 and lower lows, with the exception of 2020, perhaps. But I think the dollar is going to continue to go down. 

I know I am not alone in this view… If it breaks down, if you can mentally draw a trendline between that low in 2011 (DXY at 72) and the low back in 2021 (DXY at 89), if we break down below that trendline, I think it’s truly a dollar bear market. 

Should that happen, I would expect it to take out the low on this chart, so down below the level of around 72 or whatever. Now this is surreal.”  

Based on Gundlach’s diagonal trendline, the DXY needs to stay above 97 to avoid a 25% crash toward 72. At time of writing, the DXY is hovering at 98.24.

Last week, the billionaire Bond King said that the stock market, the dollar and the Treasury market are not behaving as usual, hinting at deeper concerns that are unsettling investors in US assets. According to Gundlach, foreign investors holding trillions in US assets may begin pulling out of American markets as concerns mount over the government’s unsustainable fiscal path.

Follow us on X, Facebook and Telegram

Don’t Miss a Beat – Subscribe to get email alerts delivered directly to your inbox

Check Price Action

Surf The Daily Hodl Mix

&nbsp

Disclaimer: Opinions expressed at The Daily Hodl are not investment advice. Investors should do their due diligence before making any high-risk investments in Bitcoin, cryptocurrency or digital assets. Please be advised that your transfers and trades are at your own risk, and any losses you may incur are your responsibility. The Daily Hodl does not recommend the buying or selling of any cryptocurrencies or digital assets, nor is The Daily Hodl an investment advisor. Please note that The Daily Hodl participates in affiliate marketing.

Generated Image: Midjourney

A closely followed analyst believes that gold’s bull market has entered a stage where the precious metal could go higher for longer.

Pseudonymous analyst Dave the Wave tells his 149,500 followers on the social media platform X that gold is at a point in its parabolic rally where the precious metal could easily print 2x gains.

The trader shares a chart suggesting that gold’s parabolic surge began in 2016 and could extend up to 2028 to hit a massive price target of $7,500.

“Gold entering its parabolic blow-off stage…” 

At time of writing, gold is worth $3,341.

Turning to Bitcoin, the analyst thinks that BTC is following in the bullish footsteps of gold after the crypto king took out resistance at $90,000.

“BTC is showing strength in uncertain markets due to its function as digital gold, in my opinion.”

At time of writing, Bitcoin is trading for $93,559, up over 7% in the last 24 hours.

Other market analysts are also bullish on gold and Bitcoin. Adam Kobeissi, the founder and editor-in-chief of The Kobeissi Letter, says that both BTC and gold are surging higher as market participants rush to seek shelter in safe-haven assets.

“Gold and Bitcoin are now aligning for the first time in months.

Since April 7th, Gold is up over 15% while Bitcoin is up over 12%.

Why is this happening?

Markets are pricing-in US Dollar weakness and more instability.

Bonds are no longer a preferred safe haven.” 

Follow us on X, Facebook and Telegram

Don’t Miss a Beat – Subscribe to get email alerts delivered directly to your inbox

Check Price Action

Surf The Daily Hodl Mix

&nbsp

Disclaimer: Opinions expressed at The Daily Hodl are not investment advice. Investors should do their due diligence before making any high-risk investments in Bitcoin, cryptocurrency or digital assets. Please be advised that your transfers and trades are at your own risk, and any losses you may incur are your responsibility. The Daily Hodl does not recommend the buying or selling of any cryptocurrencies or digital assets, nor is The Daily Hodl an investment advisor. Please note that The Daily Hodl participates in affiliate marketing.

Generated Image: DALLE3

Trusted Editorial content, reviewed by leading industry experts and seasoned editors. Ad Disclosure

Lately, the Bitcoin market has been seeing some notable adjustments in its price and key metrics even as volatility continues to overshadow the broader crypto market. With positive developments emerging in the market, bullish momentum appears to be building as the price reclaims the $85,000 mark again.

CME Open Interest Decline Hints At Consolidation Phase 

Bitcoin’s price is gaining traction due to growing bullish sentiment in the market. Prior to the renewed price shift toward the upside, BTC’s CME Open Interest has declined significantly in the past few months, indicating a slowdown in institutional trading activity. 

Alphractal, an advanced investment and on-chain data platform highlighted that the recent drop in open interest is the largest that flagship asset has ever seen. This substantial decline indicates that traders may be adopting a cautious approach in light of ongoing market uncertainties and price fluctuations.

A fall in open interest typically implies a shift in behavior, with some investors abandoning holdings. The development coincides with a renewed upward move, signaling that the market might be cooling off after a prolonged bearish performance. 

After examining the Bitcoin Open Interest Delta metric in the 90-day time frame, the platform noted that the drop is valued at around $10 billion. Such a notable value reflects the huge positions closed by institutional investors over the 3-month period.

While the 90-day Open Interest Delta reveals a sharp drop, the 30-day Open Interest Delta seems to have stopped its descent. Furthermore, the Open Interest Delta in the 7-day time frame is now transitioning into positive territory.

In other words, the BTC CME data is still pessimistic in the medium term, while positions seem to be entering a consolidation phase in the short term. In this scenario, selling pressure is likely to reduce in the short term even though it is still present in the overall view.

Thus far investors are monitoring the trend’s influence on BTC as prices move to challenge key resistance levels. This is because the market’s reaction to this drop in open interest could pave the way for Bitcoin’s next major move.

New BTC Whales Are Entering The Market

Recent data shows that new Bitcoin whales are entering the market in spite of the drop in open interest. Market expert Onchained revealed that wallet addresses holding at least 1,000 BTC are aggressively accumulating more coins, which signals strong confidence in its long-term prospects. This persistent buying reflects a rising demand for the asset among institutional and high-net-worth players.

Over time, these holders have established themselves as some of the most significant players in the market with a total of 1 million BTC acquired since November 2024. Their accumulation rate has significantly increased as the whales purchased 200,000 BTC this month alone in recent weeks.

Featured image from Unsplash, chart from Tradingview.com

Editorial Process for bitcoinist is centered on delivering thoroughly researched, accurate, and unbiased content. We uphold strict sourcing standards, and each page undergoes diligent review by our team of top technology experts and seasoned editors. This process ensures the integrity, relevance, and value of our content for our readers.

Smartwatches and smart rings are “wellness” devices. They may have some FDA-approved sensors, but there’s always fine print saying to take worrying readings with a grain of salt. But smartwatch and smart ring makers are aiming for medical-grade accuracy at all costs (literally). Not necessarily for your peace of mind, but because there’s profit to be had if the healthcare industry buys in.

The OnePlus Watch 3 dominated headlines last week because of its 5-day battery, so you probably missed the news about OnePlus opening a €13.5 million 4,840m² Health Lab in Guangdong, China. Run by “medical professionals and multidisciplinary software and hardware engineers,” it’s designed for “long-term research collaborations” with over 30 medical companies and research institutions to study athletes’ physiological data.

As a side benefit, OnePlus will use lab sensors to “improve the ability of self-developed algorithms, allowing smartwatches to better monitor exercise capacity and cardiopulmonary health.”

That may all sound a bit intense, but it’s no surprise. Dive into the career pages for Apple and Google, and you’ll find open jobs related to clinical studies, health sensor development, data center construction, health privacy, biophotonics — the list truly goes on and on. Cardiologists and smartwatch engineers have intertwined career paths in Big Tech.

Some of this research goes into new health data points; Apple is reportedly closing in on blood pressure tracking, while a Samsung exec hinted last month that non-invasive blood glucose monitoring is coming soon. Pulling that off takes serious R&D.

Other research focuses on better HR algorithms for athletes, like Google claiming the Pixel Watch 3 has the “most accurate heart rate for running yet” to try and pull customers away from fitness brands like Garmin and Polar. This watch was also the first with a “Loss of Pulse” feature.

But to be frank, courting athletes or consumers with health issues won’t justify this investment. Google didn’t buy Fitbit for $2.1 billion just to make its future Pixel Watches more accurate, and OnePlus’s new sports lab isn’t really about the casual athletes that wear its watches.

I believe a business-to-business (B2B) battle is coming for smartwatches (and smart rings) that are all trying to be the clinical, portable option for other industries. They’re all racing to collect your data and use it to self-improve their results until they can aim their sights higher. And you getting heart health warnings or daily workout recommendations is only a side effect.

Big Tech x Healthcare = profit?

The other smartwatch health news that prompted this column was Apple announcing its latest Health Study on how to use technology to “predict, detect, monitor, and manage changes in participants’ health,” across “a number of health and disease areas, including activity, aging, cardiovascular health, circulatory health, cognition, hearing, menstrual health, mental health, metabolic health, mobility, neurologic health, respiratory health, sleep, and more.”

This ambitious, holistic study isn’t being handled in a creepy way: It’s an opt-in program with options on what you share with researchers, and Apple itself doesn’t get identifying information.

What it will get is the overall results, from potentially millions of customers, showing which data its watches successfully track and which areas it fails at, adding context that it can’t normally find out on its own.

That kind of data can be incredibly valuable for preventative care, if it can analyze your health and workout trends and warn you of potential changes to your physiology or mental capacity. That could help you, but it’ll certainly help Apple keep you in its device ecosystem if it keeps marketing its Watches as life-saving.

Apple Watch | Dear Apple | Apple – YouTube

Watch On

Everyone is intrigued by blood pressure and glucose, but we’re seeing right now how smartwatches are analyzing your AGEs Index, arterial stiffness, and other niche bodily health information that’s tied to long-term health warning signs. I don’t think any consumers were asking for this; I think it’s a proof of concept for doctors to prove how useful these devices can be if they join forces.

Imagine if Apple partnered with your healthcare provider and could key in its watches to look out for specific biomarkers related to your condition or genetics. Some smartwatches can already collect data to send to your doctor, but perhaps these apps could automatically send reports, either at regular intervals or whenever there’s a sustained issue with a given metric.

‘Wellness’ is becoming old news

Smart ring sales are so niche that they’re barely worth mentioning compared to smartwatches. But I think it’s relevant that so many smart ring brands at CES pushed their medical-grade accuracy and brought up unprompted the idea of B2B sales to medical companies.

The Circular Ring 2 ditched the company’s trademark haptic engine for an FDA-approved ECG; in the CEO’s words, they’re transitioning from wellness to an alternative for “expensive” and “invasive” medical checks. The Evie Ring got FDA approval for blood oxygen readings, and its CEO also labeled it as a “clinical-grade device for B2B channels.” Ultrahuman wants you to send them blood so they can compare your smart ring data against your biomarkers, and Oura has its new Symptom Radar to link your biometrics with possible causes.

These new companies want to leapfrog wellness straight into the health industry for a reason. Either they think it’s a market ready to be tapped, or they think “wellness” alone will be seen as less marketable or profitable very soon. Whether smart rings are successful against Big Tech brands with more resources to throw into this gambit, they’re shooting their shot.

Is this a good or a bad trend? Yes.

There’s nothing inherently wrong with Apple Watches, Android smartwatches, or smart rings becoming so accurate that they can be relied upon for clinical trials. You can be skeptical that they’re as accurate as these companies want them to be, but I won’t censure them for striving for something potentially unattainable instead of coasting on “wellness” estimates.

What I worry about — and I’ve written about this before — is that it’s genuinely tough to be confronted by bad smartwatch readings on a daily basis.

Anyone would want their watch to catch signs of a heart attack so you can call your doctor. But if they start tracking your body’s poor health markers that signal potential issues years or decades down the line, will that help you turn your life around, or just send you spiraling into stress and fatalism?

I know someone who spotted a potential kidney issue because their smart scale told them they were constantly dehydrated no matter how much water they drank. This was vital information to know, but in the aftermath, the smart scale app continued to warn them. They started checking this data more often, hoping lifestyle changes would immediately fix the problem; when nothing helped, they felt hopeless.

Of course I want to know if I have arterial stiffness or high blood sugar, but once I do know, I’ll continue to be confronted by this information. Smartwatches have all these gamefied tools like daily rings meant to encourage you to become healthier, but some health issues can’t be solved by a gung-ho attitude.

I won’t be surprised if, within the next five to ten years, we start seeing more doctors prescribing smartwatches and smart rings for at-home monitoring as an affordable alternative to expensive equipment, with these brands offering a spinoff healthcare app that highlights specific information shared with you and your doctor.

The current AI revolution will play into this, of course. Medical journals are already being fed into specialized AIs; the next step is for your actual health data and testing results to power future insights. Apple’s research study and OnePlus’s specialized lab will only become increasingly common, feeding AI data that (again) these companies can sell to healthcare providers.

The side effect of this is simple: You’re going to get bombarded with more and more health and wellness information the moment you put on your smartwatch. And some people will be overwhelmed by it.

You can mentally prepare yourself for bad news before visiting a doctor; it’s harder to do the moment you wake up and see a health warning in your smartwatch’s Morning Report.